Investors are considering various pharmaceutical and healthcare exchange-traded funds (etfs), including the iShares U.S. Pharmaceuticals ETF (IHE). The IHE is being compared to other etfs, such as the State Street XPH, Invesco Pharmaceuticals ETF (PJP), and iShares IBB, to determine which one may be a better investment. The suitability of the IHE and other etfs as investments is being evaluated, with some outlets also discussing other related etfs, like those focused on healthcare providers or building and construction.